About the Journal
The Acta Pharmacologica Sinica (APS) sencourages submissions from all areas of pharmacology and the life sciences. Please go to Aims and scope page for more details.
Acta Pharmacologica Sinica is led by Editor-in-Chief Professor DING, Jian, please go to ‘about the editors’ page for further information.
Acta Pharmacologica Sinica's international Editorial Board spans the breadth of the coverage of the journal –read more about the Editorial Board.
Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper. The overall 2019 metrics for Acta Pharmacologica Sinica are as follows:
2 Year Impact Factor: 5.064*
5 Year Impact Factor: 4.588*
JCR Rank*: 42/177(Q1) CHEMISTRY, MULTIDISCIPLINARY; 26/270(Q1) PHARMACOLOGY & PHARMACY
Immediacy Index: 1.525*
Eigenfactor Score: 0.00931*
Article Influence Score: 0.912*
Total webpage views, 2019: 417,702
Total successful full-text article requests, 2019: 511,928
Number of days from acceptances at publisher to published online: 45 days
CSA Medical Biotechnology
Current Contents/Life Sciences
ISSN and eISSN
The international standard serial number (ISSN) for APS is 1671-4083, and the electronic international standard serial number (eISSN) is 1745-7254.
Acta Pharmacologica Sinica now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.
Find out more about RSS feeds, how to download an RSS reader and see all the news feeds offered by Springer Nature.
The editorial policies of this publication are determined jointly by its Editorial Board and Springer Nature in accordance with the legal and regulatory requirements of China.